Summary & Overview
HCPCS Level II J2471: Pantoprazole (Hikma) Injection, 40 mg
HCPCS Level II code J2471 denotes a 40 mg injectable dose of pantoprazole manufactured by Hikma and specified as not therapeutically equivalent to J2470. This distinction matters for payers and providers because it affects billing specificity, formulary placement, and substitution rules for injectable proton pump inhibitors used in acute care and outpatient infusion settings nationwide. Accurate coding supports proper reimbursement and inventory management for hospital outpatient departments, infusion centers, and clinics.
Key payers in the coverage landscape include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of payer coverage patterns, coding and billing benchmarks, and the clinical context for using injectable pantoprazole formulations. The publication summarizes coding implications related to therapeutic nonequivalence, compares pricing and utilization benchmarks where available, and outlines common administrative considerations relevant to facility and professional claims.
The piece provides national-level guidance on where this code is typically used, expected sites of service, and the operational impact on drug administration workflows. Data elements that are not supplied in the input are identified as unavailable.
Billing Code Overview
HCPCS Level II code J2471 represents an injection of pantoprazole (Hikma), 40 mg, explicitly noted as not therapeutically equivalent to J2470. This code describes a single-dose injectable proton pump inhibitor formulation produced by Hikma Pharmaceuticals.
Service Type: Pharmacologic / Injectable medication administration
Typical Site of Service: Outpatient infusion or clinic-based injection
Clinical & Coding Specifications
Clinical Context
A typical patient is an adult hospitalized for an acute upper gastrointestinal bleed or severe gastroesophageal reflux disease requiring intravenous acid suppression when oral therapy is not feasible. For example, a 68-year-old patient admitted from the emergency department with melena, hemodynamic instability, and end-stage dysphagia who cannot tolerate oral medications receives an IV dose of pantoprazole. The medication is administered by inpatient nursing staff in the hospital or by an infusion nurse in an ambulatory infusion center. The clinical workflow includes order entry by the treating physician (hospitalist, gastroenterologist, or emergency physician), pharmacy verification and compounding of the J2471 pantoprazole 40 mg injection (brand specified as Hikma and documented as not therapeutically equivalent to J2470), bedside administration, and documentation of dose, route, lot number, and time in the medication administration record. Billing uses the HCPCS Level II code J2471 for the specific pantoprazole product; if additional services are rendered (e.g., procedural sedation, endoscopy), those are coded separately with appropriate CPT and modifier usage. Patient monitoring for response and adverse effects follows standard inpatient protocols.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 |